Apr 5, 2022
Dr. Adam Kaplin is the Chief Scientific Officer of MyMD Pharmaceuticals which is developing a drug that gets to the cause of inflammation. Since chronic inflammation is a factor in pathological aging, managing inflammation shows opportunities for slowing aging. Their lead drug MyMD-1 is a TNF-a inhibitor that can cross...
Apr 5, 2022
Dr. Adam Kaplin is the Chief Scientific Officer of MyMD Pharmaceuticals which is developing a drug that gets to the cause of inflammation. Since chronic inflammation is a factor in pathological aging, managing inflammation shows opportunities for slowing aging. Their lead drug MyMD-1 is a TNF-a inhibitor that can cross...
Jan 11, 2022
Dr. Hing Wong is the Founder and CEO of HCW Biologics and a pioneer in the field of inflammaging which recognizes that as we age, chronic inflammation can trigger a range of age-related diseases. Their proprietary platform TOBI is using a unique Tissue FactOr-Based Scaffold to build multifunctional fusion molecules to...
Jan 11, 2022
Dr. Hing Wong is the Founder and CEO of HCW Biologics and a pioneer in the field of inflammaging which recognizes that as we age, chronic inflammation can trigger a range of age-related diseases. Their proprietary platform TOBI is using a unique Tissue FactOr-Based Scaffold to build multifunctional fusion molecules to...
Oct 20, 2021
Gary Rotman and Bruce Barnet are Co-Founders of SiMPL Technology, a company designing and selling simple tech products for seniors and their caregivers. With a particular focus on people with cognitive challenges and discomfort with digital technology, SiMPL is bringing solutions to the market that solve such challenges...